Technologies such as the Second Sight eye prosthesis can bring back basic vision to some blind people. However, the results are difficult to imagine for those not using such systems. Researchers at the University of Washington wanted to find out what it’s really like to see using a bionic eye, so they performed a […]
The post Si (Read more...)
Regeneron reported $999 million in total revenue in the second quarter, a 50% increase compared with $666 million in the same quarter of 2014, according to a press release. Net sales for Eylea (aflibercept) in the U.S. were reported at $655 million, a …
Last night we attended the unveiling of JINS SCREEN glasses at the company’s eyewear store in San Francisco, their only US location. The company is one of the largest makers of eyeglasses in Japan and Asia, and now with its Bay Area debut JINS has decided to expand to the US. While the firm has […]
SEATTLE–(BUSINESS WIRE)–Acucela Inc. (TOKYO:4589) (“Acucela” or the “Company”), a clinical-stage biotechnology company that specializes in discovering and developing novel drug candidates to potentially treat and slow the progression of sight-threatening ophthalmic diseases, announced today that it has hired Dr. Lukas Scheibler as Executive Vice President of Translational Medicine. Dr. Scheibler joins Acucela after a 13-year career in research and development, business development and clinica
BRUSSELS / SOMERSET, N.J.–(BUSINESS WIRE)–European Pricing Platform® (EPP) and its forum partner, Alliance Life Sciences, announce the upcoming 5th EPP Life Sciences Pricing Forum, 21 – 23 September, Montreux.
SAN DIEGO–(BUSINESS WIRE)–ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous sy…